Differences in the burden of psychiatric comorbidity in MS vs the general population

Neurology

Volumn 85, Issue 22, 2015, Pages 1972-1979

  Marrie, Ruth Ann ^a   Fisk, John D ^b   Tremlett, Helen ^c   Wolfson, Christina ^d   Warren, Sharon ^e   Tennakoon, Aruni ^g   Leung, Stella ^a   Patten, Scott B ^f  

^a UNIVERSITY OF MANITOBA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BIPOLAR DISORDER; CANADA; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; FEMALE; HUMAN; INCIDENCE; MALE; MENTAL DISEASE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; MIDDLE AGED;

ADULT; AGED; ANXIETY DISORDERS; BIPOLAR DISORDER; CANADA; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; SCHIZOPHRENIA;

EID: 84948953642     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002174     Document Type: Article

References (40)

1. Marrie RA, Horwitz R, Cutter G, Tyry T. Cumulative impact of comorbidity on quality of life in MS. Acta Neurol Scand 2012; 125: 180-186
2. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997; 54: 531-533
3. Marrie R, Reider N, Cohen J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J 2015; 21: 305-317
4. Marrie RA, Fisk JD, Yu BN, et al. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 2013; 13: 16
5. Horton M, Rudick RA, Hara-Cleaver C, Marrie RA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 2010; 35: 83-90
6. Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and under-treated. Mult Scler 2009; 15: 385-392
7. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376-378
8. Johannson V, Lundholm C, Hillert J, et al. Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort. Mult Scler J 2014; 20: 1881-1891
9. Thielscher C, Thielscher S, Kostev K. The risk of developing depression when suffering from neurological diseases. Ger Med Sci 2013; 11: Doc02
10. Dormuth CR, Hemmelgarn BR, Paterson JM, et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. Br Med J 2013; 346: f880
11. British Columbia Ministry of Health [creator] [2012]. Discharge Abstract Database (Hospital Separations) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015
12. British Columbia Ministry of Health [creator] [2012]. Medical Services Plan (MSP) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015
13. British Columbia Ministry of Health [creator] [2012]. Consolidation File (MSP Registration & Premium Billing) [online]. Available at: http://www.popdata.bc.ca/data. Accessed April 1, 2015
14. Marrie RA, Yu N, Blanchard JF, Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology 2010; 74: 465-471
15. Marrie RA, Fisk J, Stadnyk K, et al. The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada. Can J Neurol Sci 2013; 40: 824-831
16. Marrie RA, Fisk JD, Stadnyk KJ, et al. Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia. Chronic Dis Inj Can 2014; 34: 145-153
17. Yasui Y, Liu Y, Neglia J, et al. A methodological issue in the analysis of second-primary cancer incidence in longterm survivors of childhood cancers. Am J Epidemiol 2003; 158: 1108-1113
18. Neyeloff J, Fuchs S, Moreira L. Meta-analyses and Forest plots using a Microsoft Excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 2012; 5: 52
19. Patten SB, Berzins S, Metz LM. Challenges in screening for depression in multiple sclerosis. Mult Scler J 2010; 16: 1406-1411
20. Demakis GJ, Buchanan R, Dewald L. A longitudinal study of cognition in nursing home residents with multiple sclerosis. Disabil Rehabil 2009; 31: 1734-1741
21. Marrie RA, Yu BN, Leung S, et al. The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology 2013; 40: 85-92
22. Nuyen J, Schellevisa FG, Satarianob WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol 2006; 59: 1274-1284
23. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602
24. Kingwell E, van der Kop M, Zhao Y, et al. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 2012; 83: 61-66
25. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med 2013; 10: e1001547
26. Baxter AJ, Vos T, Scott KM, et al. The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010. Int J Methods Psychiatr Res 2014; 23: 422-438
27. Vasiliadis HM, Lesage A, Adair C, Boyer R. Service use for mental health reasons: cross-provincial differences in rates, determinants, and equity of access. Can J Psychiatry 2005; 50: 614-619
28. Kisely S, Lin E, Gilbert C, Smith M, Campbell LA, Vasiliadis HM. Use of administrative data for the surveillance of mood and anxiety disorders. Aust NZ J Psychiatry 2009; 43: 1118-1125
29. Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006; 51: 84-90
30. Schaffer A, Cairney J, Cheung A, Veldhuizen S, Levitt A. Community survey of bipolar disorder in Canada: lifetime prevalence and illness characteristics. Can J Psychiatry 2006; 51: 9-16
31. Supina AL, Patten SB. Self-reported diagnoses of schizophrenia and psychotic disorders may be valuable for monitoring and surveillance. Can J Psychiatry 2006; 51: 256-259
32. Steel Z, Marnane C, Iranpour C, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol 2014; 43: 476-493
33. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008; 102: 1-18
34. Carta MG, Moro MF, Lorefice L, et al. The risk of bipolar disorders in multiple sclerosis. J Affect Disord 2014; 155: 255-260
35. Arnold LM. Gender differences in bipolar disorder. Psychiatr Clin North Am 2003; 26: 595-620
36. Beiske AG, Svensson E, Sandanger I, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 2008; 15: 239-245
37. Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis: a comparative populationbased study in Nord-Trøndelag County, Norway. Mult Scler J 2009; 15: 1495-1501
38. Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM. Major depression in multiple sclerosis. Neurology 2003; 61: 1524-1527
39. Jensen MP, Smith AE, Bombardier CH, Yorkston KM, Miro J, Molton IR. Social support, depression, and physical disability: age and diagnostic group effects. Disabil Health J 2014; 7: 164-172
40. Rucker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol 2008; 8: 79